---
title: Methotrexate (INICET Cheat Sheet)
markmap:
  colorFreezeLevel: 6
---

## Methotrexate

### Mechanism
- Folate Antagonist
- **DHFR Inhibitor** (Dihydrofolate Reductase)
  - Blocks dTMP, purine synthesis
  - Inhibits DNA/RNA synthesis
- **Immunomodulation** (Lower doses)
  - Inhibits **AICAR Transformylase**
  - Increases **Adenosine** levels (anti-inflammatory)

### Uses
- **Chemotherapy**
  - **ALL** (Acute Lymphoblastic Leukemia)
  - Choriocarcinoma
  - Lymphomas
  - Osteosarcoma
  - Head & Neck Cancers
- **Autoimmune Diseases**
  - **Rheumatoid Arthritis (RA)** (Anchor drug)
  - Psoriasis
  - **Psoriatic Arthritis**
  - SLE (Systemic Lupus Erythematosus)
  - IBD (Inflammatory Bowel Disease)
  - Vasculitis
- **Ectopic Pregnancy**
- Medical Abortion (part of regimens)

### Dosing & Admin
- **Weekly Dosing**
  - **Standard for RA/Psoriasis/Autoimmune**
  - Reduces toxicity risk significantly
- **Daily Dosing**
  - Some Chemo regimens
- **High Dose MTX**
  - Certain Cancers (Osteosarcoma, ALL, Lymphoma)
  - Requires **Leucovorin Rescue**
- **Intrathecal MTX**
  - **CNS prophylaxis/treatment** (ALL)
  - High risk of neurotoxicity

### Toxicity & Side Effects
- **Myelosuppression**
  - **Dose-limiting**
  - Leukopenia, Thrombocytopenia, Anemia, **Pancytopenia**
- **Hepatotoxicity**
  - **Elevated LFTs** (Transaminitis)
  - Fibrosis, **Cirrhosis** (Chronic use, risk with alcohol/obesity)
- **Pulmonary Toxicity**
  - **MTX Lung** (Acute or Chronic Interstitial Pneumonitis/Fibrosis)
  - Fever, cough, dyspnea, hypoxemia
  - Non-infectious
- **Mucositis** (Stomatitis, Oral ulcers)
- **Nephrotoxicity** (Acute Kidney Injury)
  - High doses (crystalluria)
  - Requires hydration & urine alkalization
- **Teratogenicity**
  - **Absolute Contraindication in Pregnancy**
  - Neural tube defects, multiple malformations
  - Requires effective contraception
- **Neurotoxicity**
  - High dose IV (encephalopathy)
  - **Intrathecal** (Acute: chemical arachnoiditis; Chronic: leukoencephalopathy, paraplegia)
- Gastrointestinal: Nausea, Vomiting, Diarrhea
- Alopecia
- Photosensitivity
- Fatigue
- Headache
- **Lymphoma** (MTX-associated lymphoproliferative disorder - reversible upon stopping MTX)

### Monitoring
- **CBC** (Baseline, Weekly/Biweekly initially, then Periodic)
- **LFTs** (Baseline, Periodic - e.g., q1-3 months)
- **Renal Function** (Creatinine, GFR - Baseline, Periodic)
- Chest X-ray (Baseline for RA/Psoriasis, if symptoms)
- Serum Methotrexate levels (Routine for High Dose MTX protocols)
- **Pregnancy Test** (Before starting in women of childbearing potential)
- Albumin (Risk factor for toxicity)
- Viral hepatitis screen (Baseline)

### Management of Toxicity / Rescue
- **Stop Methotrexate**
- **Leucovorin Rescue (Folinic Acid)**
  - **Mandatory after High Dose MTX**
  - Used for significant toxicity at any dose
  - Provides reduced folate, bypassing DHFR inhibition
  - Timing & Dose critical (based on MTX dose/levels)
- **Folic Acid Supplementation**
  - **Used with Low Dose Weekly MTX** (RA, Psoriasis)
  - Reduces non-hematologic side effects (**N/V, Mucositis, LFT elevation**)
  - **Does not reduce efficacy** for inflammation at therapeutic doses
  - Dose varies (e.g., 1-5mg weekly, 24h after MTX)
- Hydration (especially high dose)
- Urine Alkalization (high dose)
- Glucocorticoids (for **MTX Lung**)
- Granulocyte Colony Stimulating Factor (G-CSF) for severe neutropenia

### Drug Interactions
- **NSAIDs** (Aspirin, Ibuprofen, Naproxen, etc.)
  - **Increase MTX levels** (Decreased renal excretion, displacement from albumin)
  - **Risk of severe myelosuppression, AKI**
  - **Concomitant use requires caution/monitoring**, especially at higher MTX doses
- **Trimethoprim-Sulfamethoxazole** (Cotrimoxazole)
  - Potentiates **myelosuppression** (Both inhibit folate pathway - different enzymes)
  - **Avoid concomitant use**
- Probenecid (Decreases MTX renal excretion -> increased MTX levels)
- PPIs (Omeprazole, Pantoprazole - may increase MTX levels, clinical significance debated at low MTX doses)
- Other myelosuppressive drugs
- Other hepatotoxic drugs

### Contraindications
- **Pregnancy & Breastfeeding**
- **Significant Renal Impairment** (CrCl < 30-50 ml/min)
- **Significant Hepatic Impairment** / Liver Disease (Cirrhosis, Active Hepatitis)
- Pre-existing **Pulmonary Fibrosis**
- **Active Severe Infection**
- Active Peptic Ulcer Disease / Stomatitis
- **Alcoholism**
- Pre-existing Blood Dyscrasias (severe anemia, leukopenia, thrombocytopenia)
- Immunodeficiency Syndromes
- Hypersensitivity to MTX

### INICET Buzzwords / High Yield
- **DHFR Inhibitor**
- **Leucovorin Rescue**
- **Weekly Dosing** (Autoimmune)
- **MTX Lung** (Interstitial Pneumonitis)
- **Myelosuppression**
- **Hepatotoxicity / Cirrhosis**
- **Teratogenicity** (Pregnancy)
- **Folic Acid Supplementation** (Reduces low-dose side effects)
- **NSAID Interaction** (Increased toxicity risk)
- **Trimethoprim-Sulfamethoxazole Interaction** (Severe myelosuppression)
- **Ectopic Pregnancy**
- **Intrathecal Neurotoxicity**
- **AICAR Transformylase** (Mechanism in RA)
- **Megaloblastic Anemia** (Rare, due to folate deficiency)
- **Monitoring: CBC, LFT, Creatinine**


